FITCHBURG, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Integrated Pharmaceuticals, Inc. (IntePharm) (Pink Sheets: INTP) announced today that it is introducing a calcium product that can include an artificial sweetener such as Splenda(TM), Sweet 'N Low(TM), or Equal(TM). This new product can be added to hot or cold beverages as an ordinary sweetener, delivering calcium in a manner that has essentially the same taste as the sweetener itself, and no noticeable effect on the color or odor of the beverage. Dr. Chinmay Chatterjee said that this product will deliver calcium, one of the most essential nutrients, as and when needed. IntePharm's new product increases the absorbability of calcium more than any other calcium supplement currently available in the market. "With this product introduction, IntePharm expects to deliver the right kind of calcium supplement to those who regularly use artificial sweeteners in their beverages, including the nation's 18 million diabetics, an additional 41 million who are at risk for developing the disease and all those who are constantly watching their weight," said Dr. Chatterjee, President and CEO of Integrated Pharmaceuticals, Inc. To the best of IntePharm's knowledge, no other manufacturer has a similar product on the market. Dr. Chatterjee said that this product would be very beneficial for overweight adult and children because calcium helps dieters to lose weight. He pointed out that 65% of adult males, 55% of adult females and more than 10% of children are overweight. Dr. Chatterjee pointed out that more than 5 billion Splenda(TM) packs were used last year or almost 9,000 packs per minute, and said that a considerable fraction of these users could benefit from the use of the Company's new product. This product is also expected to be an essential ingredient for Calcium fortified drinks. Close to a $1.8 billion worth of fortified beverages were sold last year. Dr. Chatterjee said that taking calcium in commonly-used beverages could become the most effective way of delivering calcium because of its convenience and most importantly, the body absorbs calcium better in frequent, small doses rather than a single large tablet. According to the US Surgeon General's report of 2004, approximately 34 million Americans are at risk to suffer from osteoporosis and 10 million Americans already suffer from the disease. In addition to being essential for these people, calcium also has significant beneficial effects for obesity, high blood pressure, colon cancer and kidney stones. Dr. Chatterjee said that the achievement of delivering calcium and a sweetener in one simple packet is a major scientific and business milestone for the company. IntePharm could achieve this combined delivery format due to its next generation manufacturing technology which produces extremely pure quality of the product, a quality level that exceeds even the US Pharmacopoeia standards at an affordable price. Dr. Chatterjee mentioned further that the company is in active discussion with several nationwide and regional chain stores for distribution of its new product in the very near future. "We are excited to introduce IntePharm's innovative technology to well-positioned marketers servicing retail food and drug chains, mass merchandisers, foodservice chains, nutraceutical companies and multi-level marketing firms in both the US and Canada." About IntePharm IntePharm is an emerging producer of pharmaceuticals, specialty compounds for the pharmaceutical, nutraceutical and functional food and beverage industries. In addition to manufacturing products, IntePharm discovers and develops more efficient and cost-effective manufacturing and mineral delivery processes. These processes are developed using a comprehensive technology platform that combines metabolic engineering, cellular genetics, advanced bioprocess engineering, and computer simulation science. The company owns several other pending patents for new products and technologies for immediate commercialization in food and nutritional products market. For further information please contact Dr. Chinmay Chatterjee, Integrated Pharmaceuticals, Inc. (IntePharm), at (978) 696-0020, or visit http://www.intepharm.com/ DATASOURCE: Integrated Pharmaceuticals, Inc. CONTACT: Dr. Chinmay Chatterjee of Integrated Pharmaceuticals, Inc., +1-978-696-0020 Web site: http://www.intepharm.com/

Copyright